Brief: Gain Therapeutics Announces Preclinical Data Showing Restoration Of Enzymatic Function With Novel Allosteric Regulators In Gm1 Gangliosidosis Model
01/12/2023 13:12
Gain Therapeutics Inc GANX.O :
* GAIN THERAPEUTICS ANNOUNCES PRECLINICAL DATA SHOWING
RESTORATION
OF ENZYMATIC FUNCTION WITH NOVEL ALLOSTERIC REGULATORS IN GM1
GANGLIOSIDOSIS MODEL
Source text for Eikon: ID:nGNXbdy0Gc
Further company coverage: GANX.O
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall